Certified Advisory Corp Takes Position in Colgate-Palmolive (CL)

Certified Advisory Corp bought a new position in shares of Colgate-Palmolive (NYSE:CL) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,896 shares of the company’s stock, valued at approximately $143,000.

Several other large investors also recently modified their holdings of the stock. BlackRock Inc. boosted its position in shares of Colgate-Palmolive by 1.4% during the fourth quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock worth $3,950,614,000 after acquiring an additional 711,972 shares during the last quarter. Renaissance Technologies LLC lifted its position in Colgate-Palmolive by 42.4% during the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after purchasing an additional 2,903,800 shares during the last quarter. Geode Capital Management LLC lifted its position in Colgate-Palmolive by 2.1% during the fourth quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock valued at $675,751,000 after purchasing an additional 188,455 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Colgate-Palmolive by 25.3% during the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after purchasing an additional 1,385,946 shares during the last quarter. Finally, First Eagle Investment Management LLC lifted its position in Colgate-Palmolive by 35.8% during the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after purchasing an additional 1,750,417 shares during the last quarter. Hedge funds and other institutional investors own 73.64% of the company’s stock.

How to Become a New Pot Stock Millionaire

CL has been the subject of several research reports. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Societe Generale lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective for the company. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price objective for the company. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research report on Tuesday, December 19th. Finally, Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $77.76.

In related news, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the transaction, the insider now owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John J. Huston sold 1,524 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $70.17, for a total transaction of $106,939.08. Following the completion of the transaction, the senior vice president now directly owns 87,376 shares in the company, valued at approximately $6,131,173.92. The disclosure for this sale can be found here. In the last three months, insiders sold 455,707 shares of company stock worth $32,443,427. Insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive stock opened at $68.38 on Friday. Colgate-Palmolive has a 12 month low of $68.19 and a 12 month high of $77.91. The firm has a market cap of $60,239.98, a price-to-earnings ratio of 29.99, a PEG ratio of 2.55 and a beta of 0.79. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter in the prior year, the firm posted $0.75 earnings per share. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. sell-side analysts expect that Colgate-Palmolive will post 3.18 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be paid a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This represents a $1.68 annualized dividend and a dividend yield of 2.46%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.

ILLEGAL ACTIVITY WARNING: “Certified Advisory Corp Takes Position in Colgate-Palmolive (CL)” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3298457/certified-advisory-corp-takes-position-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Wheaton Precious Metals Co.  Receives Average Recommendation of “Buy” from Brokerages
Wheaton Precious Metals Co. Receives Average Recommendation of “Buy” from Brokerages
Zacks: Brokerages Expect James River Group Holdings Ltd  Will Post Quarterly Sales of $214.55 Million
Zacks: Brokerages Expect James River Group Holdings Ltd Will Post Quarterly Sales of $214.55 Million
RSGPcoin  Tops 1-Day Volume of $0.00
RSGPcoin Tops 1-Day Volume of $0.00
Privatix  Price Hits $2.15 on Major Exchanges
Privatix Price Hits $2.15 on Major Exchanges
Eaton Co.  Expected to Announce Earnings of $1.06 Per Share
Eaton Co. Expected to Announce Earnings of $1.06 Per Share
Micro Focus  Earning Somewhat Favorable Press Coverage, Study Finds
Micro Focus Earning Somewhat Favorable Press Coverage, Study Finds


© 2006-2018 Ticker Report. Google+.